The Allergic Asthma Therapeutics Market is Trending by Growing Prevalence of Allergies
![]() |
Allergic Asthma Therapeutics Market |
The allergic asthma therapeutics
market comprises anti-asthmatic and bronchodilator drugs that provide relief
from symptoms caused due to asthma. These drugs work by relaxing airway
muscles, reducing mucus production and swelling in airways. The growth in
number of cases of allergic asthma due to rising environmental pollution and
lifestyle changes has increased the demand for therapeutics which can
effectively manage the condition.
The
Global Allergic Asthma Therapeutics Market is estimated to be valued at US$
8.37 Bn in 2024 and is expected to exhibit a CAGR of 13% over the forecast
period 2024 to 2031.
Key players operating in the allergic asthma therapeutics are Ansarada Pty
Ltd., Brainloop AG (Diligent Corporation), CapLinked, Citrix Systems Inc.,
Datasite Global Corporation, DealRoom Inc., EthosData, Firmex Inc, FORDATA sp.
z o.o., iDeals Solutions Group, Intralinks Holdings Inc. (SS&C
Technologies), SecureDocs Inc., ShareVault (Pandesa Corporation) and SmartRoom
(BMC Group).
Rising air pollution levels,
prevalence of Allergic
Asthma Therapeutics Market Demand and changing lifestyle have increased
the prevalence of allergic asthma over the years. This has boosted the demand
for effective therapeutic drugs for treatment and management of the condition.
Major companies are focusing on geographical expansion and new product launches
to expand their market share and better serve patients across various
countries.
Increasing research funding for development of novel biologic drugs for asthma
is a key trend in the market. Biologics have potential to provide better
management of allergic triggers and symptoms with reduced side effects as
compared to conventional drugs. Regional governments and pharma companies are
supporting research through funding and partnerships. Other major trends
include growing adoption of digital health tools for asthma monitoring and
management and home healthcare devices facilitating self-administration of
drugs.
Porter’s Analysis
Bargaining power of buyers: Buyers have high bargaining power due to availability of substitute therapies but brand loyalty provides advantage to existing players.
Bargaining power of suppliers: Suppliers have moderate bargaining power due to availability of alternative suppliers of raw materials and presence of contracting organizations.
Threat of new substitutes: Substitutes present low threat as they treat different disease indications.
Competitive rivalry: High due to presence of many global and regional players.
Geographical Regions
North America accounts for the largest market share in terms of value due to
high healthcare expenditure and increasing allergic asthma prevalence in the
region.
Asia Pacific is poised to grow at the fastest rate during the forecast period
driven by rising healthcare standards, growing medical tourism, and increasing
investments by key players in the region.
Get
More Insights On, Allergic
Asthma Therapeutics Market
About Author:
Money Singh is a seasoned content writer with over four years of experience in
the market research sector. Her expertise spans various industries, including
food and beverages, biotechnology, chemical and materials, defense and
aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)
Comments
Post a Comment